Goserelin plus tamoxifen versus tamoxifen alone, in pre-menopausal or peri-menopausal patients with hormone receptor-positive early-stage breast cancer: A randomised controlled trial in China
2013 ◽
Vol 93
(1)
◽
pp. 114-121
◽
Keyword(s):